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Background: While limited evidence suggests that omega-3 supplementation may reduce antisocial behavior in
children, studies have not reported on posttreatment follow-up and most treatment periods have been of short
duration. This study tests the hypothesis that omega-3 supplementation over 6 months will reduce behavior problems
in children both at the end of treatment and at 6 months post treatment.Methods: In this randomized, double-blind,
placebo-controlled, stratified, parallel-group trial, a community sample of 8–16 year old childrenwere randomized into
a treatment group (N = 100) and a placebo-control group (N = 100). The supplementation consisted of a fruit drink
containing 1 g/day of omega-3 or a placebo consisting of the same fruit drink without omega-3. Participants,
caregivers, and research assistants were blinded to group assignment. The primary outcomemeasures of externalizing
and internalizing behavior problems were reported by both caregivers and their children in a laboratory setting at
0 months (baseline), 6 months (end of treatment) and 12 months (6 months post treatment), together with the
secondary outcome measures of parental antisocial behavior. Data were analyzed on an intention-to-treat basis
including all participants. Trial registration: ClinicalTrials.gov: http://clinicaltrials.gov/ct2/show/NCT02016079?
term=mauritius&rank=2. Results: Significant group 9 time interactions were observed with the treatment group
showing long-term improvements in child behavior problems. The average posttreatment effect size was d = .59.
Effects were documented for parent reports, but with the exception of proactive and reactive aggression, child-report
data were nonsignificant. Parents whose children took omega-3 showed significant posttreatment reductions in their
own antisocial and aggressive behavior. This improvement in caregiver behavior partly mediated the improvements
observed in child behavior. Conclusions: Findings provide initial evidence that omega-3 supplementation can
produce sustained reductions in externalizing and internalizing behavior problems. Results are the first to report
improvements in caregiver behavior, and to establish this improvement as a part-mechanism for the efficacy of
omega-3. Keywords: Omega-3, externalizing, internalizing, aggression, randomized trial.
Introduction
Poor nutritional status during pregnancy has been
found to predispose to antisocial personality disor-
der in adulthood (Neugebauer, Hoek, & Susser,
1999), while poor nutrition in early childhood is
associated with increased aggressive and con-
duct-disordered behavior in childhood and adoles-
cence (Liu, Raine, Venables, Dalais, & Mednick,
2004). Poor nutrition is hypothesized to negatively
impact brain structure and function which in turn
predisposes to risk factors for antisocial behavior
(Liu, 2011; Raine, 2008). Brain abnormalities have
been found to characterize not just adult offenders
(Glenn & Raine, 2014), but also conduct disordered
children and children with callous-unemotional
traits (Fairchild et al., 2011; Viding et al., 2012).
As such, poor nutrition is a plausible risk factor
for the development of antisocial and aggressive
behavior.
Given this nutrition – brain – antisocial behavior
linkage, improving nutrition may help improve child
behavior problems. Vitamin and mineral supple-
mentation may reduce antisocial behavior, although
evidence here is relatively sparse (Benton, 2007).
Tryptophan supplementation (an essential amino
acid) reduces aggression and increases agreeable-
ness in some studies (Young, 2013). Another nutri-
tional component coming under increasing scrutiny
is omega-3. Fish consumption across the world is
negatively correlated with cross-country homicide
rates (Hibbeln, 2001). Two randomized controlled
trials (RCTs) have shown that omega-3 supplemen-
tation reduces antisocial behavior in young prison-
ers in both England (35% reduction) and the
Netherlands (34% reduction) (Gesch, Hammond,
Hampson, Eves, & Crowder, 2002; Zaalberg, Nijman,
Bulten, Stroosma, & van der Staak, 2010), and
reduces aggression in male adult men without aConflict of interest statement: See acknowledgment section.
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history of aggression (Long & Benton, 2013). Find-
ings from RCTs in children and adolescents are
mixed, with some finding limited evidence for effi-
cacy (Gustafsson et al., 2010) while others do not
(Milte et al., 2012). The latter study had 52% power
to detect a significant effect, and consequently null
results may be partly due to lack of adequate power.
Several factors may contribute to conflicting find-
ings. Dosages of omega-3 have varied across studies
and are generally relatively low – with some as low as
124 mg of omega-3/day (Gesch et al., 2002). Sec-
ond, treatment length has been relatively short, with
some as short as 1 month with a median of approx-
imately 3 months (Sinn, Milte, & Howe, 2010). Third,
because there appears to be no comprehensive
meta-analysis of omega-3 supplementation on child
antisocial behavior, there is a clear need for further
RCTs on this behavior problem. Fourth, sample sizes
are relatively small not just in studies on antisocial
behavior, but also in clinical trials in general, with
50% having fewer than 70 participants (Califf et al.,
2012).
There are also methodological limitations in prior
studies. Some are correlational, yet RCTs are the
building blocks of evidence-based practice (Mau-
ghan, 2013) and are critical for parsing causality.
Second, no study on behavior problems has fol-
lowed up children post treatment to assess for
long-term efficacy. Third, studies have not examined
changes in caregiver behavior; improvements in the
child’s behavior could plausibly improve the behav-
ior of the parent, and this could further contribute
to a delayed long-term improvement in child behav-
ior. Fourth, it is unclear whether findings from the
clinic and correctional settings generalize to the
community. Fifth, while children with cal-
lous-unemotional traits have relatively poor treat-
ment outcome (Frick, Ray, Thornton, & Kahn,
2014), we know of no attempts to reduce such traits
using nutritional intervention.
To help address these issues, this study’s primary
aim was to test whether omega-3 supplementation
reduces child and adolescent antisocial/aggressive
behavior. The main hypothesis was that omega-3
supplementation will reduce externalizing behavior
problems both at the end of treatment and also
6-months post treatment. Secondary aims were to
assess for reduction in internalizing behavior prob-
lems, and to examine any influence of nutritional
supplementation to the child on their caregiver’s
antisocial behavior, and whether any such parental
change could contribute to child behavior change.
Methods
Trial design
The design consisted of a randomized, double-blind, pla-
cebo-controlled, stratified, parallel-group trial (1:1 ratio) of
children in the community. Trial design remained unchanged
throughout the study.
Study setting
The study took place in interview rooms at the Joint Child
Health Project headquarters in Quatre Bornes, Mauritius, from
November 2009 to December 2011. Further details of this
country and past research can be found in Raine, Liu,
Venables, Mednick, and Dalais (2010). The study was regis-
tered in ClinicalTrials.gov under the title ‘Effect of Omega-3




Participants consisted of 200 children of parents who them-
selves had participated in the Mauritius Child Health Project
(Raine et al., 2010). Children had to be aged between 8 and
16 years old, willing to participate in an RCT, and residing in
the community. Exclusion criteria consisted of: (a) allergy to
fish or fish products, (b) use of fish-oil supplementation in the
past 6 months, (c) intellectual disability. Written informed
consent was obtained from the parents, while assent was
obtained from the child. During consenting, participants were
informed of the study hypothesis that omega-3 may help
improve child behavior. Ethical approval was obtained from
IRB boards in Mauritius (Ministry of Health) and the US
(University of Pennsylvania).
Reviews of RCTs have commented that median sample sizes
in RCTs are relatively modest, with estimates of 46, 54, 65, and
80 from different reviews (Moher, 2010), and which also
characterize omega-3 RCTs of psychopathology (Sinn et al.,
2010). We consequently aimed for a somewhat larger study to
detect a small-to-medium effect size. Our sample size of 200
had power to detect an effect size of d = .35 with power of .80,
a = .05, one-tailed.
Omega-3 intervention
Omega-3 supplementation. This consisted of a 200 ml
drink (Smartfish Recharge). The base drink in both treatment
and control conditions consisted of fruit juice from apple, pear,
pomegranate, aronia, and passion fruit. It also contained
vitamin D (0.85 lg) and antioxidants (ferric reducing ability of
plasma value of 0.71 mmol/100 g). For the treatment condi-
tion only, a total of 1000 mg of omega-3 (300 mg of DHA,
200 mg of EPA, 400 mg of alpha-linolenic acid, and 100 mg of
DPA) was added to the base drink. Placebo drinks were
matched exactly with the fish-oil drink in terms of size,
appearance, and flavor.
This drink was chosen because: (a) it contains an apprecia-
bly higher dosage of omega-3 than standard capsules in a
relatively small liquid quantity (60.6% of the size of a standard
can of cola) suitable for child consumption, (b) the fruit-fla-
vored drink may be better tolerated and result in higher
compliance with children than standard capsules.
Treatment duration and administration. Treatment
duration was 6 months. This duration was chosen because
prior treatment studies have usually been 2–4 months (Sinn
et al., 2010), and a somewhat longer treatment period may be
more effective in producing longer-term brain and behavioral
change. The omega-3 drink was administered by the parents to
their children each day at a suitable time.
Outcome measures
The predefined primary outcome measures were externalizing
behavior problems including aggressive behavior. Secondary
outcomes included internalizing behavior problems and paren-
tal aggressive and psychopathic behavior.
© 2014 Association for Child and Adolescent Mental Health.
2 Adrian Raine et al.
Child behavior checklist (CBCL) and youth self
report (YSR). The CBCL (parent report) and YSR (child
report) are well-standardized, extensively used psychometric
instruments with high reliability/validity in many countries
(Achenbach & Rescorla, 2001). Measurement invariance of the
CBCL has also been documented on this cohort in Mauritius
(Yarnell et al., 2013). The CBCL/YSR contains two empirically
derived broadband scales (externalizing/internalizing) and
eight syndrome scales. Externalizing behavior consists of
Aggressive Behavior and Rule-Breaking Behavior scales, while
the internalizing behavior domain consisted of Anxious/
Depressed, Withdrawn/Depressed, and Somatic Complaints
scales. Additional syndrome scales include Attention Prob-
lems, Social Problems, Thought, and Other Problems.
Reactive-proactive aggression questionnaire
(RPQ). Children completed this self-report instrument
which yields scales of reactive, proactive, and total aggression
(Raine et al., 2006). Reliability and validity have been docu-
mented in Baker, Raine, Liu, and Jacobson (2008), Fossati
et al. (2009), and Fung, Raine, and Gao (2009).
The antisocial personality screening device
(APSD). This 20-item scale assesses parent-reported child
and adolescent psychopathic traits (Frick, Bodin, & Barry,
2000). It consists of three subscales to assess callous-unemo-
tional traits, narcissism, and impulsivity.
Psychopathic personality inventory (PPI). Parents
completed the short version of the self-report Psychopathic
Personality Inventory (PPI – Lilienfeld & Andrews, 1996). It
yields a global psychopathy score, and eight subscales mea-
suring social potency, cold-heartedness, fearlessness, impul-
sive nonconformity, stress immunity, Machiavellian
egocentricity, blame externalization, and carefree nonplanful-
ness. The PPI was designed for use in nonclinical settings and
has been shown to be reliable and valid in community samples
(Lilienfeld & Andrews, 1996).
Randomization and stratification
After giving informed consent, participants were randomized
into treatment and placebo groups with blocking on a 1:1 ratio
(Suresh, 2011). Prior to initial group assignment, matched
pairs of participants were created from the computer data--
base, with matching on age band (8–10, 11–13, 14–16), gender
(male/female), and ethnicity (Indian/Creole). This stratifica-
tion procedure aims to balance groups on key demographic
variables. Within each of the 100 pairs, restricted randomiza-
tion to group was conducted using a computer-generated list of
random numbers generated by SPSS.
Adherence to protocol
Adherence to the treatment regimen was assessed at the end of
treatment by asking caregivers how often the drink had been
consumed (number of drinks/week). Adherence was also
assessed by assays of omega-6 and omega-3 from finger-prick
blood taken at baseline and 6 months (end of treatment). For
detailed methods see Lin, Loewke, Hyun, Leazer, and Hibbeln
(2012).
Statistical methods
An intention-to-treat (ITT) design using all randomly assigned
participants (200) was employed for all data analyses. Data
missing due to loss at follow-up were imputed using the last
observation carried forward strategy (White, Horton, & Pocock,
2011). The ITT approach is considered a gold standard for
RCTs, is endorsed by CONSORT, respects initial randomiza-
tion, and provides unbiased estimates of the effect of treatment
assignment on outcome measures (Shrier et al., 2014) as well
as a more realistic estimate of treatment effects in the real
world where people drop out of treatment (Del Re, Maisel,
Blodgett, & Finney, 2013).
Analyses focused on documenting group 9 time interac-
tions, with effect sizes calculated using partial g2. Differences
in baseline scores were compared using two-tailed indepen-
dent t-test. Where differences were observed (only for child
self-report RPQ), baseline scores were entered as covariates to
equalize groups at baseline.
To assess whether any improvement in parental behavior
may partly account for the treatment effect on child behavior,
mediation analyses were performed using the PROCESS SPSS
macro (Hayes, 2013). To test significance of the indirect effects
(i.e. mediation), bias-corrected confidence intervals for the
indirect effectswere generated using 10,000bootstrap samples.
Bootstrappingwasused because it constitutes a nonparametric
resampling procedure that makes more realistic assumptions
on the sampling distribution of the indirect effect (MacKinnon,
Lockwood,&Williams, 2004). To assess extent ofmediation, the
reduction in variance explained in treatment outcome by the
intervention after controlling for improved parental behavior
(the mediator) was calculated in a two-step regression. All
analyses were conducted using SPSS (version 20; IBM, Amonk,
NY, USA) .
Results
Participant flow and recruitment
Participant flow and recruitment details are outlined
in the Supplemental Table S1. No participant loss
was observed on baseline assessment after random-
ization. Of the 200 participants, 16 (8%) were lost to
follow-up at either 6 or 12 months (5 from omega-3,
11 from placebo – see Table S1 for details of reasons
for loss). Groups did not significantly differ in this
attrition (v2 = 2.51, df = 1, p = .11).
Demographics and adherence to protocol
Demographics. Demographic data are reported in
Table 1. No significant group differences were
observed, documenting that stratification proce-
dures were successful.
Adherence to protocol. Average number of drinks
taken per week for each group are provided in
Table 1. There was no significant group difference
in compliance rates (p = .73).
Adherence to the protocol was also assessed using
blood omega-3 fatty acid levels (see Table 1). A
significant group 9 time interaction indicated that
groups did not differ at baseline, but post treatment
(6 months), the omega-3 group had significantly
higher omega-3 levels than controls (p < .001), indi-
cating increased omega-3 levels over treatment.
Child behavioral problems
Means and SDs on parent and child outcome mea-
sures for children at all three time points,
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group 9 trial interactions, effect sizes for interac-
tions and posttreatment group differences are
detailed in Table 2.
Parent report. Significant group 9 time interac-
tions were observed for all internalizing and exter-
nalizing subscales, except for somatic complaints.
A significant interaction was also obtained for
callous-unemotional traits. All other results were
nonsignificant. Interactions for externalizing, inter-
nalizing, and callous-unemotional behavior are
illustrated in Figure 1. The effect size for group
differences at 12 months for all CBCL behavior
problem scales was d = .59 (95% C.I. = .84 to
.35).
Child report. In contrast to parent reports, for most
self-report measures no group 9 trial interactions
were observed. Significant interactions were, how-
ever, observed for self-report reactive (p < .0001) and
proactive (p = .02) aggression, as well as total
aggression (p < .0001). Both forms of aggression
showed significant intervention declines only in the
omega-3 group by the end of treatment at 6 months
(average d = .80, 95% C.I. = 1.08 to .52) (see
Figure S1).
Parental antisocial behavior
Means, SDs, group 9 time interactions, and post-
treatment effect sizes are shown in Table 3. Signif-
icant group 9 time interactions were observed for
total PPI scores, six of the eight PPI subscales, and
reactive (but not proactive) aggression. As indicated
in Figure 2, total psychopathy scores declined at
6 months in both groups during treatment, but while
scores for placebo parents returned to baseline at
follow-up, the reduction in parents of the omega-3
group was maintained 6 months post treatment at
the 12 month time-point.
For reactive aggression, all groups showed
declines over time, but the within-group posttreat-
ment decline was greater in the omega-3 group than
in controls with respect to both 6-12 months with-
in-group change scores (t = 2.15, df = 198, p = .04,
d = .30, CI = .03 to .58) and also 0–12 month
change scores (t = 2.12, df = 198, p = .04, d = .30,
CI = .02 to .58). Groups did not differ from each
other at the end point (12 months).
Influence of placebo effects
Because the above results documented a
short-term placebo effect for parent reports of child
behavior, groups were examined for differences in
their belief in group assignment, and whether this
could explain group differences in child behavior.
By the end of treatment at 6 months, caregivers
with children randomized into the treatment group
were more likely to believe their children were
receiving omega-3 (97%) compared to the placebo
group (53%) (v2 = 51.63, df = 1, p < .0001,
g = .51).
To assess if this belief influenced parental percep-
tion of their child’s behavior, this measure was
entered as a covariate in all previously significant
analyses. After controlling for parental belief in
treatment allocation, the group 9 time interaction
for parental reports remained significant for exter-
nalizing behavior (F[2,394] = 7.59, p = .001, g2 = .04)
and internalizing behavior (F[2,394] = 6.44, p = .002,
g2 = .03). All other previously significant findings
remained significant (p < .05). One previously nonsig-
nificant interaction for narcissism became significant
after controlling for parental belief (F[2,195] = 8.44,
p = .048, g2 = .02).
Factors influencing improvement in parental
behavior
We tested whether improvements in the child’s
behavior at 12 months partly accounted for improve-
ment in their parent’s behavior at 12 months.
Improvement in child callous-unemotional traits
(indirect effect: b = .04, p < .05), reactive aggression
(indirect effect: b = .02, p < .05), and total RPQ
aggression (indirect effect: b = .02, p < .05) all sep-
arately mediated improvement in parental psychop-
athy, but not parental reactive aggression. No other
child improvements were found to mediate improved
parental behavior (p > .05). In total, improvement in
child behavior following treatment accounted for
38.7% of the improvement in parental antisocial
behavior.
Table 1 Demographic and adherence data together with
statistical comparisons for placebo and omega-3 groups
Placebo Omega-3 Statistic p
Demographics
Age (SD) 11.57 (2.12) 11.07 (2.21) t = 1.62 .11
IQ (SD) 99.94 (13.52) 101.23 (14.54) t = 0.65 .52
Sex
Female (N) 48 48 v2 = 0.0 1.0
Male (N) 52 52
Ethnicity
Indian (N) 59 57 v2 = 0.08 .77
Creole (N) 41 43
Religion










6.49 (1.04) 6.54 (0.88) t = 0.34 .73
Omega-3 blood level:
Before 21.49 (7.44) 22.73 (7.55) t = 1.16 .25
After 22.29 (7.12) 26.39 (9.33) t = 3.49 .001
© 2014 Association for Child and Adolescent Mental Health.
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Factors accounting for improvement in child
behavior
Omega-3 treatment of the child was associated with
improvements in their parent’s behavior. Improved
parental behavior may therefore partly account for
the treatment effect on child behavior.
Testing this hypothesis, changes in parental psy-
chopathy partly mediated child treatment outcomes
for callous-unemotional traits (indirect effect:
b = .06, p < .05), reactive aggression (indirect effect:
b = .06, p < .05), and total RPQ aggression (indirect
effect: b = .06, p < .05). Changes in parental reactive
aggression partly mediated child treatment effects
for anxious-depressed (indirect effect: b = .02,
p < .05). No other parental improvement mediated
improved child behavior (p > .05). In total, improve-
ment in parental behavior accounted for 60.9% of
the improvement in child antisocial behavior and
40.0% of the improvement in child anx-
ious-depressed behavior.
Adverse events
No major adverse events were reported. Minor
adverse events during the 6 month treatment period
were reported by 17 parents (8.5%) and 6 children
(3%) (see Table S2). There were no significant group
differences for parent reports (v2 = 1.61, df = 1,
p = .21) or child reports (v2 = 0.69, df = 1, p = .41).
No participant withdrew due to these minor events.
Discussion
The study’s main finding was that omega-3 supple-
mentation for 6 months resulted in a 41.6% reduction
in parent-rated child externalizing behavior half-a--
year after treatment ended. A similar long-term reduc-
tion (68.4%) was observed for internalizing behavior.
Results could not easily be attributed to placebo
expectations. Findings are mitigated by the failure to
observe similar effects for child self-reports, with the
exception of significant short-term reductions in
self-report child reactive (58.9% reduction) and pro-
active (49.7%) aggression. In the parents of treated
children, significant reductions were also observed in
parental psychopathy and reactive aggression.
Improvement in parental behavior accounted for
60.9%of the improvement inchildantisocial behavior.
To our knowledge, this is the first study to document
support for the longer-term posttreatment efficacy of
omega-3 in reducing child and adolescent externaliz-
ing and internalizing behavior, and to document
reduced antisocial behavior in caregivers.
Improvements in child behavior problems
In addition to significant improvements in aggressive
and antisocial behaviors, the medium effect size
(d = .58) for long-term improvement in cal-
lous-unemotional traits is notable given the recent
addition of this trait as a specifier in DSM-V (Amer-
ican Psychiatry Association, 2013) and the increas-
ing interest in child psychopathic-like behavior
(Frick et al., 2014). This finding might be expected
as low omega-3 has been associated with high
callous-unemotional traits in children with ADHD
(Gow et al., 2013). In contrast, 18 out of 20 treat-
ment studies report poorer outcomes in antisocial
adolescents with callous-unemotional traits com-
pared to those without these traits (Frick et al.,
2014). Furthermore, there is very little research
focused on callous-unemotional traits themselves
(Frick et al., 2014). In this context, omega-3 inter-
ventions may be an option in tackling this particular
treatment challenge.
While the primary focus of this study was on
antisocial and aggressive behavior, positive treatment
effects were also observed for almost all internalizing
behavior problems. While omega-3 supplementation
has been shown in some studies to reduce childhood
depression (Nemets, Nemets, Apter, Bracha, & Bel-
Figure 1 Significant group 9 time interactions (with standard
error bars) for parents’ reports of child externalizing behavior,
child internalizing behavior, and child callous-unemotional traits
© 2014 Association for Child and Adolescent Mental Health.
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maker, 2006), overall the evidence from RCTs of
omega-3 on depression is mixed (Giles, Mahoney, &
Kanarek, 2013). Similarmixed conclusions have been
drawn for omega-3 RCTs on ADHD,with some reviews
suggesting small positive effects (Bloch & Qawasmi,
2011) while others suggest null results (Gillies, Sinn,
Lad, Leach, & Ross, 2012). Clearly, the current
findings on internalizing behavior must be treated
with caution, while also suggesting that efficacy for
internalizing behavior problems is worthy of further
investigation.
Mechanisms of action
While the study cannot identify proximal neurobio-
logical mechanisms whereby omega-3 results in
long-term reductions in externalizing behavior prob-
lems, callous-unemotional traits, and reactive/pro-
active aggression, this long-chain fatty acid plays a
critical role in brain structure and function, making
up approximately 35% of the cell membrane,
enhancing neurite outgrowth, and regulating both
neurotransmitter functioning and gene expression
(McNamara & Carlson, 2006). In this context an RCT
of omega-3 in children has been shown to enhance
dorsolateral prefrontal functioning (McNamara &
Carlson, 2006), a brain area found to be impaired
in antisocial individuals (Fairchild et al., 2013;
Seguin, Nagin, Assaad, & Tremblay, 2004; Yang &
Raine, 2009). Future studies could therefore test the
mediating hypothesis that omega-3 reduce antisocial
behavior by enhancing prefrontal functioning.
Despite this study limitation, we were able to
assess the mediating role of parental behavior on
treatment efficacy. Giving children omega-3 resulted
in improvements in their caregivers’ antisocial
behavior compared to controls. This parental
improvement partly mediated improvements in child
behavior produced by omega-3 supplementation.
Specifically, reductions in parental psychopathy
accounted for 60.9% of the improvement in child
antisocial behavior. Because caregivers and their
children have reciprocal effects on one another
(Dodge & Pettit, 2003), it is not surprising to antic-
ipate improvements in child behavior evoking
improvement in parental behavior that further
improves child behavior. Surprising however, no
prior study of omega-3 on any child behavior has,
to our knowledge, tested this reciprocity hypothesis.
While initial, this finding highlights an intermediary
parental behavioral mechanism for improved child
behavior following omega-3 supplementation that
requires further investigation.
Placebo effects
Improvements in child behavior were not explained
by parent’s belief in treatment allocation, with the
group 9 time interaction effects remaining signifi-
cant after controlling for this belief. On the contrary,
effects for the narcissism component of the child
psychopathy measure became significant after con-
trolling for this confound. These findings dictate
against a placebo effect as an explanation for the
sustained improvement in child behavior over time.
Nevertheless, the placebo group did show improve-
ments during the initial test period up to 6 months
on several outcomes. While expectation of improve-
ment with treatment enrollment likely contributed to
this effect, it is also conceivable that the antioxidants
and vitamin D contained in the placebo drink may
have contributed to this transient change given some
evidence suggesting potential efficacy of micronutri-
ent supplementation for antisocial behavior (Benton,
2007).
Reporter effects
Improvement in child behavior following omega-3
consumption was observed for parent reports, but
with the exception of proactive and reactive aggres-
sion, no effects were observed with child self reports.
Similar results have been observed in other studies.
The only two RCTs of omega-3 conducted in prison
which documented behavioral improvement as mon-
itored by others either failed to observe effects for self
reports (Zaalberg et al., 2010) or did not report
findings beyond baseline data (Gesch et al., 2002).
Similarly Long and Benton (2013) found no effect of
omega-3 on self-report aggression, but did find
reduced aggression on a laboratory behavioral
measure of aggression.
The fact that effects were nevertheless obtained for
child self-reported proactive and reactive aggression
Figure 2 Significant group 9 time interactions (with standard
error bars) for parents’ self reports of their own psychopathy and
reactive aggression
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may be due to the fact that in the construction of this
self-report measure, it was argued that children
know better than their parents the underlying motive
for aggressive behavior, a factor critical for distin-
guishing goal-oriented proactive aggression from
aggression in reaction to a provocation (Raine et al.,
2006). While the null results for other self report
should be viewed as a limitation, from a clinical
perspective the very large majority of clinic referrals
for behavioral problems are from parents, not chil-
dren. Consequently, the current findings for parental
reports may have clinical relevance.
Study limitations and generalizability
Regarding limitations, the ITT approach which ana-
lyzed all participants irrespective of treatment com-
pletion is viewed as an important defense against
selection bias (White et al., 2011) and is viewed as
the primary approach to data analysis in RCTs
(Hernan & Hernandez-Diaz, 2012). It is nevertheless
believed to underestimate treatment effects in pla-
cebo-controlled RCTs (Hernan & Hernandez-Diaz,
2012). The sample size of 200 is not large, although
given that more than 50% of all registered RCTs have
fewer than 70 participants by design (Califf et al.,
2012), the completed sample and associated statis-
tical power compares favorably to other trials. While
long-term posttreatment improvement was observed,
we caution that this time period is 6 months and
findings may or may not extend for longer. Further-
more, long-term effects were not observed for proac-
tive and reactive aggression.
Caveats are also needed on generalizability of
findings. While Mauritius is a developed country,
future generalization to other countries and other
ethnic groups is required. Furthermore, the research
staff reported unusually strong enthusiasm to par-
ticipate in this treatment study compared to the risk
research normally conducted at the Joint Child
Health Project. This again cautions against general-
ization of findings from this RCT to other interna-
tional settings.
Conclusions
In conclusion, this RCT shows that 6 months of
omega-3 supplementation in fruit juice drink form
results in a 42–68% reduction in parent-reported
externalizing and internalizing behavior problems in
community-residing children and adolescents, with
improvement continuing 6 months after treatment
cessation. While replication and generalization to
other countries is critical, the potential clinical
promise is that these nutrients can shift the distri-
bution of behavior problems to a lower level in
the general population and that more severe behav-
ioral problems that are significant risk factors for
serious adult violence and psychopathology may be
ameliorated.
Supporting information
Additional Supporting Information may be found in the
online version of this article:
Table S1. CONSORT flow diagram.
Table S2. Minor adverse events.
Figure S1. Child proactive and reactive aggression.
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Key points
• It is unclear whether omega-3 supplementation can reduced externalizing and internalizing behavior
problems in child and adolescent populations.
• This RCT showed that 6 months of omega-3 supplementation in fruit juice form produced long-term
posttreatment reductions in parent-reported externalizing behavior problems (41.6%) and internalizing
behavior problems (68.4%).
• Caregivers of children receiving omega-3 also showed significant reductions in their own antisocial behavior.
• Improvements in parental behavior accounted for 60.9% of the improvement in child behavior.
• This is the first study to report not just posttreatment reductions in child antisocial behavior, but also to
document improvements in parental behavior that in part explain treatment efficacy.
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